Yayın:
Catecholaminergic and Cholinergic Systems Mediate Beneficial Effect of Vortioxetine on Diabetes-Induced Neuropathic Pain

dc.contributor.authorTURAN YÜCEL, NAZLI
dc.contributor.authorDEMİR ÖZKAY, ÜMİDE
dc.contributor.authorCAN, ÖZGÜR DEVRİM
dc.contributor.authorÜmide Demir Özkay
dc.contributor.authorÖzgür Devrim Can
dc.contributor.orcid0000-0002-0371-2703
dc.contributor.orcid0000-0003-3314-1961
dc.contributor.orcid0000-0002-5470-0139
dc.contributor.orcid0000-0002-6773-4266
dc.contributor.orcid0000-0002-2260-3174
dc.date.accessioned2025-11-13T11:00:20Z
dc.date.issued2023-04-10
dc.identifier.doihttps://doi.org/10.3390/biomedicines11041137
dc.identifier.endpage1137
dc.identifier.issn2227-9059
dc.identifier.issue4
dc.identifier.openalexW4363648330
dc.identifier.startpage1137
dc.identifier.urihttps://hdl.handle.net/11421/5927
dc.identifier.urihttps://doi.org/10.3390/biomedicines11041137
dc.identifier.volume11
dc.language.isoen
dc.relation.ispartofBiomedicines
dc.rightsopenAccess
dc.subjectVortioxetine
dc.subjectNeuropathic pain
dc.subjectAllodynia
dc.subjectPharmacology
dc.subjectHyperalgesia
dc.subjectMedicine
dc.subjectCholinergic
dc.subjectNeuralgia
dc.subjectEndocrinology
dc.subjectAnesthesia
dc.subjectAntidepressant
dc.subjectInternal medicine
dc.subjectNociception
dc.subjectReceptor
dc.subjectHippocampus
dc.subject.sdg3
dc.titleCatecholaminergic and Cholinergic Systems Mediate Beneficial Effect of Vortioxetine on Diabetes-Induced Neuropathic Pain
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5018664863
local.authorid.openalexA5017325490
local.authorid.openalexA5020313406

Dosyalar

Koleksiyonlar